STOCK TITAN

[Form 4] Synovus Financial Corp. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

John H. Irby, a director of Synovus Financial Corp. (SNV), reported a purchase of common stock on 08/11/2025 through the issuer's Director Stock Purchase Plan. The report shows 123 shares purchased at $46.91, bringing Mr. Irby’s directly held shares to 21,451 shares following the transaction.

The filing also discloses indirect holdings attributed to related trusts: 37,718 shares by the Sarah C. Irby 2011 Family Trust, 9,885 by the Sarah C. Irby Revocable Trust, 4,181 by the Virginia Bradley Irby Equalization Trust, and 4,182 by the Elizabeth Neal Irby Equalization Trust. The acquisition is described as made through the Director Stock Purchase Plan.

John H. Irby, un amministratore di Synovus Financial Corp. (SNV), ha dichiarato l'acquisto di azioni ordinarie il 08/11/2025 tramite il Piano di acquisto azionario per amministratori della società. La segnalazione indica l'acquisto di 123 azioni a $46.91, portando le azioni detenute direttamente dal sig. Irby a 21,451 azioni dopo l'operazione.

La comunicazione riporta inoltre partecipazioni indirette attribuite a trust correlati: 37,718 azioni dal Sarah C. Irby 2011 Family Trust, 9,885 dal Sarah C. Irby Revocable Trust, 4,181 dal Virginia Bradley Irby Equalization Trust e 4,182 dall'Elizabeth Neal Irby Equalization Trust. L'acquisizione è indicata come effettuata tramite il Piano di acquisto azionario per amministratori.

John H. Irby, director de Synovus Financial Corp. (SNV), informó la compra de acciones ordinarias el 08/11/2025 a través del Plan de Compra de Acciones para Directores de la emisora. El informe muestra 123 acciones compradas a $46.91, elevando las acciones que el Sr. Irby posee directamente a 21,451 tras la transacción.

La presentación también revela participaciones indirectas atribuidas a fideicomisos relacionados: 37,718 acciones por el Sarah C. Irby 2011 Family Trust, 9,885 por el Sarah C. Irby Revocable Trust, 4,181 por el Virginia Bradley Irby Equalization Trust y 4,182 por el Elizabeth Neal Irby Equalization Trust. La adquisición se describe como realizada a través del Plan de Compra de Acciones para Directores.

John H. Irby는 Synovus Financial Corp. (SNV)의 이사로서 08/11/2025에 발행회사의 이사 주식 매입 계획을 통해 보통주를 매입했다고 보고했습니다. 보고서에는 123주를 주당 $46.91에 매입하여 해당 거래 후 Irby 씨가 직접 보유한 주식이 21,451주가 되었다고 기재되어 있습니다.

신고서에는 또한 관련 신탁에 귀속된 간접 보유분이 공개되어 있습니다: Sarah C. Irby 2011 Family Trust가 37,718주, Sarah C. Irby Revocable Trust가 9,885주, Virginia Bradley Irby Equalization Trust가 4,181주, Elizabeth Neal Irby Equalization Trust가 4,182주를 보유하고 있습니다. 이 인수는 이사 주식 매입 계획을 통해 이루어진 것으로 설명됩니다.

John H. Irby, administrateur de Synovus Financial Corp. (SNV), a déclaré un achat d'actions ordinaires le 08/11/2025 dans le cadre du plan d'achat d'actions pour administrateurs de l'émetteur. Le rapport indique l'achat de 123 actions à $46.91, portant le nombre d'actions détenues directement par M. Irby à 21,451 après la transaction.

Le dépôt révèle également des participations indirectes attribuées à des trusts liés : 37,718 actions par le Sarah C. Irby 2011 Family Trust, 9,885 par le Sarah C. Irby Revocable Trust, 4,181 par le Virginia Bradley Irby Equalization Trust et 4,182 par le Elizabeth Neal Irby Equalization Trust. L'acquisition est décrite comme réalisée via le plan d'achat d'actions pour administrateurs.

John H. Irby, ein Direktor von Synovus Financial Corp. (SNV), meldete am 08/11/2025 den Kauf von Stammaktien über den Aktienkaufplan für Direktoren des Emittenten. Die Meldung zeigt 123 erworbene Aktien zu je $46.91, wodurch Irbys direkt gehaltene Aktien nach der Transaktion 21,451 Stück betragen.

Die Einreichung offenbart außerdem indirekte Beteiligungen, die verbundenen Trusts zugeschrieben werden: 37,718 Aktien durch den Sarah C. Irby 2011 Family Trust, 9,885 durch den Sarah C. Irby Revocable Trust, 4,181 durch den Virginia Bradley Irby Equalization Trust und 4,182 durch den Elizabeth Neal Irby Equalization Trust. Der Erwerb wird als über den Aktienkaufplan für Direktoren getätigt beschrieben.

Positive
  • Director purchase reported: John H. Irby purchased 123 shares through the Director Stock Purchase Plan.
  • Purchase price disclosed: the acquisition price is stated as $46.91 per share.
  • Clear post-transaction ownership: direct beneficial ownership is reported as 21,451 shares.
  • Detailed indirect holdings: the filing lists trust-held shares with exact amounts (37,718; 9,885; 4,181; 4,182), improving transparency.
Negative
  • None.

Insights

TL;DR: Director John H. Irby purchased 123 SNV shares at $46.91, modestly increasing direct ownership to 21,451 shares.

The transaction is explicit and small in size: 123 shares at $46.91 executed on 08/11/2025 via the Director Stock Purchase Plan. The filing provides clear post-transaction direct ownership of 21,451 shares, plus several material indirect trust holdings. On its face, this disclosure is routine and provides transparency on insider holdings but does not, by itself, indicate a material change to Synovus’s capital structure or control.

TL;DR: Purchase executed under a director plan and multiple indirect trust holdings are disclosed, reflecting standard insider reporting practices.

The Form 4 notes the acquisition was made through the issuer's Director Stock Purchase Plan, a standard mechanism for directors to buy equity. The report also itemizes indirect beneficial ownership held by four named trusts with specific share counts, clarifying the reporting person’s related-party holdings. The disclosure is complete regarding the reported holdings and source of the purchase.

John H. Irby, un amministratore di Synovus Financial Corp. (SNV), ha dichiarato l'acquisto di azioni ordinarie il 08/11/2025 tramite il Piano di acquisto azionario per amministratori della società. La segnalazione indica l'acquisto di 123 azioni a $46.91, portando le azioni detenute direttamente dal sig. Irby a 21,451 azioni dopo l'operazione.

La comunicazione riporta inoltre partecipazioni indirette attribuite a trust correlati: 37,718 azioni dal Sarah C. Irby 2011 Family Trust, 9,885 dal Sarah C. Irby Revocable Trust, 4,181 dal Virginia Bradley Irby Equalization Trust e 4,182 dall'Elizabeth Neal Irby Equalization Trust. L'acquisizione è indicata come effettuata tramite il Piano di acquisto azionario per amministratori.

John H. Irby, director de Synovus Financial Corp. (SNV), informó la compra de acciones ordinarias el 08/11/2025 a través del Plan de Compra de Acciones para Directores de la emisora. El informe muestra 123 acciones compradas a $46.91, elevando las acciones que el Sr. Irby posee directamente a 21,451 tras la transacción.

La presentación también revela participaciones indirectas atribuidas a fideicomisos relacionados: 37,718 acciones por el Sarah C. Irby 2011 Family Trust, 9,885 por el Sarah C. Irby Revocable Trust, 4,181 por el Virginia Bradley Irby Equalization Trust y 4,182 por el Elizabeth Neal Irby Equalization Trust. La adquisición se describe como realizada a través del Plan de Compra de Acciones para Directores.

John H. Irby는 Synovus Financial Corp. (SNV)의 이사로서 08/11/2025에 발행회사의 이사 주식 매입 계획을 통해 보통주를 매입했다고 보고했습니다. 보고서에는 123주를 주당 $46.91에 매입하여 해당 거래 후 Irby 씨가 직접 보유한 주식이 21,451주가 되었다고 기재되어 있습니다.

신고서에는 또한 관련 신탁에 귀속된 간접 보유분이 공개되어 있습니다: Sarah C. Irby 2011 Family Trust가 37,718주, Sarah C. Irby Revocable Trust가 9,885주, Virginia Bradley Irby Equalization Trust가 4,181주, Elizabeth Neal Irby Equalization Trust가 4,182주를 보유하고 있습니다. 이 인수는 이사 주식 매입 계획을 통해 이루어진 것으로 설명됩니다.

John H. Irby, administrateur de Synovus Financial Corp. (SNV), a déclaré un achat d'actions ordinaires le 08/11/2025 dans le cadre du plan d'achat d'actions pour administrateurs de l'émetteur. Le rapport indique l'achat de 123 actions à $46.91, portant le nombre d'actions détenues directement par M. Irby à 21,451 après la transaction.

Le dépôt révèle également des participations indirectes attribuées à des trusts liés : 37,718 actions par le Sarah C. Irby 2011 Family Trust, 9,885 par le Sarah C. Irby Revocable Trust, 4,181 par le Virginia Bradley Irby Equalization Trust et 4,182 par le Elizabeth Neal Irby Equalization Trust. L'acquisition est décrite comme réalisée via le plan d'achat d'actions pour administrateurs.

John H. Irby, ein Direktor von Synovus Financial Corp. (SNV), meldete am 08/11/2025 den Kauf von Stammaktien über den Aktienkaufplan für Direktoren des Emittenten. Die Meldung zeigt 123 erworbene Aktien zu je $46.91, wodurch Irbys direkt gehaltene Aktien nach der Transaktion 21,451 Stück betragen.

Die Einreichung offenbart außerdem indirekte Beteiligungen, die verbundenen Trusts zugeschrieben werden: 37,718 Aktien durch den Sarah C. Irby 2011 Family Trust, 9,885 durch den Sarah C. Irby Revocable Trust, 4,181 durch den Virginia Bradley Irby Equalization Trust und 4,182 durch den Elizabeth Neal Irby Equalization Trust. Der Erwerb wird als über den Aktienkaufplan für Direktoren getätigt beschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Irby John H.

(Last) (First) (Middle)
P.O. BOX 120

(Street)
COLUMBUS GA 31902

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SYNOVUS FINANCIAL CORP [ SNV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/11/2025 J(1) 123 A $46.91 21,451 D
Common Stock 37,718 I By Sarah C. Irby 2011 Family Trust
Common Stock 9,885 I By Sarah C. Irby Revocable Trust
Common Stock 4,181 I By Virginia Bradley Irby Equalization Trust
Common Stock 4,182 I By Elizabeth Neal Irby Equalization Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Purchased through Issuer's Director Stock Purchase Plan.
Remarks:
/s/ Mary Maurice Young 08/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did SNV director John H. Irby report on Form 4?

The Form 4 reports that John H. Irby purchased 123 shares of Synovus Financial Corp. common stock on 08/11/2025.

At what price were the SNV shares purchased by the director?

The reported purchase price was $46.91 per share.

How many SNV shares does John H. Irby directly own after the reported transaction?

The filing reports 21,451 shares beneficially owned directly following the transaction.

Were the shares purchased through a plan or open-market transaction?

Yes. The filing states the shares were purchased through the issuer's Director Stock Purchase Plan.

Does the Form 4 disclose indirect holdings for the reporting person?

Yes. Indirect holdings are disclosed for related trusts: 37,718, 9,885, 4,181, and 4,182 shares respectively.
Synovus Financia

NYSE:SNV

SNV Rankings

SNV Latest News

SNV Latest SEC Filings

SNV Stock Data

6.53B
137.94M
0.5%
88.37%
2.32%
Banks - Regional
National Commercial Banks
Link
United States
COLUMBUS